Skip to content

DIAgnosing GDM usiNg Oral Sugar InStead

Diabetes, Gestational

The purpose of this study is to compare the positive and negative effects of Dex4® tablets, as an alternative form of fast acting carbohydrate, compared to the current standard diagnostic test, glucose beverage. The investigators hypothesis that because of their availability in solid, chewable form, variety of flavours and lack of carbonation, Dex4® tablets may result in fewer side effects than glucose beverage and provide an equivalent carbohydrate challenge for diagnosis of gestational diabetes.

null

Conditions de participation

  • Sexe:

    FEMALE

  • Âges admissibles:

    0 and up

Critères de participation

Eligibility criteria must be met by 32 weeks' gestation to allow enrollment in the study.

Inclusion Criteria:

* Positive 50g GCT result between 7.8-11.0 mmol/L
* Female
* Singleton pregnancy
* Informed consent obtained and signed

Exclusion Criteria:

* Use of steroids, terbutaline, or metformin within the last 4 weeks
* Previous diagnosis of diabetes type 1 or 2 outside of pregnancy or diagnosis with any form of diabetes prior to 20 weeks of pregnancy
* Allergy to any ingredients (including the non-medicinal ingredients) in Dex4® tablets or Glucodex solution

Lieu de l'étude

Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Ilana Halperin, MD

[email protected]
416-480-6056
Étude parrainée par
Sunnybrook Health Sciences Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT05115188